Hepatitis B is curable in some people, but not all
Whether hepatitis B can be cured depends on when you caught it and how your immune system responds. If you contracted hepatitis B as an adult, your body clears the virus on its own in about 90 percent of cases — meaning you recover completely without treatment. If you contracted it as an infant or young child, your immune system is less likely to clear it naturally, and the infection often becomes chronic, lasting a lifetime. Even with chronic hepatitis B, modern antiviral medications can suppress the virus so effectively that it causes little or no liver damage.
The distinction between "cured" and "controlled" matters for how you manage the condition going forward. A true cure means the virus is completely gone from your body. Control means the virus is still present but inactive enough that it does not harm your liver or spread to others. Most people with chronic hepatitis B live long, healthy lives on antiviral treatment.
Key Takeaways
- Adults who catch hepatitis B usually clear the infection naturally without treatment, but infants and children often develop chronic infection.
- Chronic hepatitis B cannot be cured with current medications, but antiviral drugs can suppress the virus so completely that liver damage stops.
- A blood test showing undetectable viral load means the virus is controlled and you are unlikely to transmit it to others.
- Even if you have chronic hepatitis B, regular monitoring and treatment prevent serious liver disease in the vast majority of people.
How your body's response determines whether you recover naturally
When an adult is exposed to hepatitis B, their immune system usually recognizes and fights off the virus within six months. During this time, you may have no symptoms at all, or you may feel tired, have joint pain, or develop jaundice (yellowing of the skin and eyes). A blood test during this window shows that you have acute hepatitis B — a temporary infection.
Your immune system wins this fight in roughly 9 out of 10 adults. Once cleared, the virus is gone permanently, and you develop immunity. You cannot catch hepatitis B again, and you cannot pass it to others. This is a genuine cure, even though no medication was involved.
The remaining 1 in 10 adults do not clear the virus within six months. At that point, the infection becomes chronic — it persists indefinitely. This happens when your immune system fails to eliminate the virus completely, allowing it to hide in liver cells and replicate slowly over time.
Why infants and children have a different outcome
Infants and young children who contract hepatitis B almost never clear it naturally. Between 80 and 90 percent of infected infants develop chronic infection. This happens because their immune systems are still developing and cannot mount an effective response to the virus.
Most hepatitis B transmission to infants occurs at birth, when an infected mother passes the virus to her newborn. This is why pregnant people are tested for hepatitis B, and why newborns of infected mothers receive a vaccine and immunoglobulin (antibodies) within hours of birth. These preventive steps stop infection in most cases.
Children infected between ages 1 and 5 have a 30 to 50 percent chance of clearing the virus naturally. By age 6, the risk of chronic infection drops closer to adult levels. This gradual shift reflects the maturing immune system.
What antiviral medications do and do not do
Antiviral drugs for hepatitis B — such as entecavir, tenofovir, and lamivudine — do not cure the infection. Instead, they block the virus from replicating inside liver cells. When replication stops, the viral load (the amount of virus in your blood) drops dramatically, often to undetectable levels within weeks or months.
An undetectable viral load is the treatment goal. It means the virus is still in your body, but in such small amounts that standard blood tests cannot find it. At this level, the virus causes no new liver damage, and you are extremely unlikely to transmit hepatitis B to others through blood or sexual contact.
Most people with chronic hepatitis B who take antiviral medication stay on it for life. Stopping treatment usually allows the virus to rebound and the viral load to rise again. However, researchers are studying whether some people can safely stop treatment after years of undetectable viral load, so this may change.
The difference between cure and long-term control
A cure means the virus is completely eradicated from your body. Currently, no medication achieves this for chronic hepatitis B. Researchers are working on new approaches — including therapeutic vaccines and drugs that target infected liver cells — but these are still in clinical trials and not yet available for routine use.
Long-term control is what antiviral medications provide today. Your liver remains healthy, you do not develop cirrhosis or liver cancer, and you can live a normal lifespan. For most people, this is functionally equivalent to a cure in terms of quality of life and life expectancy.
The key difference emerges if you stop treatment. Someone who is cured stays well. Someone whose infection is controlled must continue medication to maintain that control. This is an important distinction for planning your long-term care, but it does not mean your life is shortened or severely restricted.
Monitoring and preventing liver damage
If you have chronic hepatitis B, your doctor will monitor your liver health through regular blood tests and ultrasound imaging. These tests measure liver enzymes, check for scarring (fibrosis), and screen for hepatocellular carcinoma, a type of liver cancer that can develop in people with long-standing infection.
Starting antiviral treatment early — before significant liver damage occurs — dramatically improves outcomes. People who begin treatment while their liver is still relatively healthy rarely develop cirrhosis or cancer, even over decades of infection.
Beyond medication, you can protect your liver by avoiding alcohol, maintaining a healthy weight, and getting vaccinated against hepatitis A (a separate virus that can cause severe illness in people with hepatitis B). These steps reduce the risk of additional liver stress.
Living with chronic hepatitis B
Chronic hepatitis B is a manageable condition. Most people on antiviral therapy have undetectable viral loads, normal liver function, and no symptoms. You can work, exercise, have relationships, and plan for the future much as anyone else would.
Disclosure to sexual partners and household contacts is important, since the virus can spread through blood exposure and, less commonly, through sexual contact. Partners can be vaccinated to prevent infection. Household contacts should also be vaccinated if they are not already immune.
Pregnancy is possible with chronic hepatitis B. If you are pregnant or planning pregnancy, your doctor will discuss whether antiviral treatment during pregnancy is needed to prevent transmission to your baby. Modern treatments are safe in pregnancy and very effective at preventing mother-to-child transmission.
Frequently Asked Questions
If I had hepatitis B as a child and recovered, can I catch it again?
No. Once your immune system clears hepatitis B, you develop lifelong immunity. You cannot be reinfected, and you do not need booster vaccines. A blood test will show antibodies that prove you are immune.
Can I stop taking antiviral medication if my viral load becomes undetectable?
Not without discussing it with your doctor first. For most people, stopping treatment allows the virus to rebound. Some research suggests certain patients may safely stop after many years of undetectable viral load, but this is not standard practice yet. Your doctor can assess whether you might be a candidate.
Does hepatitis B always lead to cirrhosis or liver cancer?
No. With early treatment and consistent use of antiviral medication, most people never develop cirrhosis or cancer. The risk is highest in people who go untreated for decades or who have additional liver stress from alcohol or other viruses.
If I have chronic hepatitis B, will I live a normal lifespan?
Yes, in most cases. People on antiviral therapy have life expectancies comparable to the general population. The key is starting treatment before major liver damage occurs and taking medication consistently as prescribed.
What is the difference between hepatitis B surface antigen and viral load?
Hepatitis B surface antigen (HBsAg) is a protein on the virus that your blood test detects to confirm infection. Viral load is the actual number of virus particles in your blood. Both are measured to diagnose and monitor hepatitis B, but viral load is what antiviral drugs directly reduce.